Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...

Sprouts Farmers Market is accelerating its expansion with an 8% store count growth expected this year. Read why SFM stock is ...

Monte Carlo simulations revealed how sector diversification and correlations impact long-term portfolio resilience. Click ...